Kinetic analysis of apolipoproteins in postprandial hypertriglyceridaemia rabbits

Laboratory Animals

Volumn 43, Issue 2, 2009, Pages 174-181

  Hata, M ^a,b   Ito, T ^a,b   Ohwada, K ^a  

^a YAMAGATA UNIVERSITY   (Japan)

^b JAC Inc   (Japan)

Author keywords

Animal model; Apolipoprotein B100; Apolipoprotein B48; PHT rabbit; Postprandial hypertriglyceridaemia

Indexed keywords

APOLIPOPROTEIN; APOLIPOPROTEIN A1; APOLIPOPROTEIN B; APOLIPOPROTEIN B100; APOLIPOPROTEIN B48; APOLIPOPROTEIN C2; APOLIPOPROTEIN E; CHYLOMICRON; LIPOPROTEIN; LIPOPROTEIN LIPASE; TRIACYLGLYCEROL; TRIACYLGLYCEROL LIPASE;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; FEEDING; FEMALE; HYPERTRIGLYCERIDEMIA; KINETICS; LIPOLYSIS; LIPOPROTEIN BLOOD LEVEL; MALE; NONHUMAN; POLYACRYLAMIDE GEL ELECTROPHORESIS; PROTEIN ANALYSIS; PROTEIN DEGRADATION; RABBIT; TRIACYLGLYCEROL LIPASE BLOOD LEVEL;

ANIMALS; ANIMALS, LABORATORY; APOLIPOPROTEINS; CHOLESTEROL; ELECTROPHORESIS, POLYACRYLAMIDE GEL; HYPERTRIGLYCERIDEMIA; LIPOPROTEINS, VLDL; LIVER; MALE; POSTPRANDIAL PERIOD; RABBITS; TRIGLYCERIDES;

ANIMALIA; ORYCTOLAGUS CUNICULUS;

EID: 63849304467     PISSN: 00236772     EISSN: None     Source Type: Journal    
DOI: 10.1258/la.2008.007004     Document Type: Article

References (18)

1. Yasue H, Ogawa H, Tanaka H, et al. Effects of aspirin and trapidil on cardiovascular events after acute myocardial infarction. Am J Cardiol 1999;83:1308-13
2. Jappesen J, Hein HO, Suadicani P, Gyntelberg F. Triglyceride concentration and ischaemic heart disease: an eight-year follow-up in the Copenhagen male study. Circulation 1998;97:1029-36
3. Hiam M, Benderly M, Brunner D, et al. Elevated serum triglyceride levels and long-term mortality in patients with coronary heart disease: the Bezafibrate Infarction Prevention (BIP) registry. Circulation 1999;100:475 - 82
4. Tomoike H, Ohwada K, Ito T. Hereditary postprandial hypertriglyceridemic rabbit model. US Patent No. US 6515196 B2. 2003
5. Ito T, Ohwada K, Tomoike H. A hereditary postprandial hypertriglyceridemic (PHT) rabbit model. Jpn J Pharmacol 2005;125:301-6
6. Kawai T, Ito T, Ohwada K, Mera Y, Matsushita M, Tomoike H. Hereditary postprandial hypertriglyceridemic rabbit exhibits insulin resistance and central obesity: a novel model of metabolic syndrome. Arterioscler Thromb Vasc Biol 2006;26:2752-7
7. Scanu AM, Edelstein C. Solubility in aqueous solutions of ethanol of the small molecular weight peptides of the serum very low density and high density lipoproteins: relevance to the recovery problem during delipidation of serum lipoproteins. Anal Biochem 1971;44:576-88
8. Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970;227:680-5
9. Havel RJ, Eder HA, Bragdon JH. The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum. J Clin Invest 1955;34:1345-53
10. Goldstein JL, Kita T, Brown MS. Defective lipoprotein receptors and atherosclerosis. Lessons from an animal counterpart of familial hypercholesterolaemia. N Engl J Med 1983;309:288-96
11. Oikawa S, Naito T. TG rich lipoproteins. Lipid 1990;1:12-19
12. Breslow JL. Apolipoprotein genetic variation and human disease. Physiol Rev 1988;68:85-132
13. Ito Y, Azrolan N, O'Connell A, Walsh A, Breslow JL. Hypertriglyceridemia as a result of human apo C-β gene expression in transgenic mice. Science 1990;249:790-3
14. Maeda N, Li H, Lee D, Oliver P, Quarfordt SH, Osada J. Targeted disruption of apolipoprotein C-III gene in mice results in hypotriglyceridemia and protection from the postprandial hypertriglyceridaemia. J Biol Chem 1994;269:23610-16
15. Yamamura T, Sudo H, Ishikawa K, Yamamoto A. Familial type I hyperlipoproteinemia caused by apolipoprotein C-II deficiency. Atherosclerosis 1979;34:53-65
16. Bjorkegren J, Packard CJ, Hamsten A, et al. Accumulation of large very low density lipoprotein in plasma during intravenous infusion of a chylomicron-like triglyceride emulsion reflects competition for a common lipolytic pathway. J Lipid Res 1996;37:76-86
17. Mahley RW, Innerarity TL, Rall SC, Weisgraber KH. Plasma lipoprotein: apolipoprotein structure function. J Lipid Res 1984;25:1277-94
18. Sakai N, Yamashita S. Treatment of Hypertriglyceridemia. Triglyceride, HDL-Cholesterol, and the Atherosclerosis. Osaka, Japan: Fuji Medical Publishing, 2001:259-69